Phase 4 Endometrial Cancer Trial, Recruiting (NCT05979493)

Phase 4 Endometrial Cancer Trial, Recruiting NCT05979493 Sponsor: Joseph Findley MD Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05979493 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have uterine fibroids (non-cancerous growths in the womb) that need to be surgically removed, while keeping your uterus intact
You are willing and able to follow all the study's requirements for the full length of the trial
You are able to sign and date a consent form agreeing to take part

Who may not be able to join:

You have already been diagnosed with anxiety or depression
You have a pre-existing condition that affects how your blood clots (confirm with trial site)
You already experience nerve pain or long-term ongoing pelvic pain
You regularly use opioid pain medicines (such as morphine or codeine) on an ongoing basis
You are unable to read and understand straightforward written questionnaires
You do not speak English
Your Body Mass Index (BMI), which is a measure of body weight relative to height, is higher than 38

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Joseph Findley, MD, University Hospitals

Phone: 3392011531

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05979493

Sponsor: Joseph Findley MD

Phase: Phase 4

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 3392011531

More information: https://clinicaltrials.gov/study/NCT05979493

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have uterine fibroids (non-cancerous growths in the womb) that need to be surgically removed, while keeping your uterus intact
You are willing and able to follow all the study's requirements for the full length of the trial
You are able to sign and date a consent form agreeing to take part

Who may not be able to join:

You have already been diagnosed with anxiety or depression
You have a pre-existing condition that affects how your blood clots (confirm with trial site)
You already experience nerve pain or long-term ongoing pelvic pain
You regularly use opioid pain medicines (such as morphine or codeine) on an ongoing basis
You are unable to read and understand straightforward written questionnaires
You do not speak English
Your Body Mass Index (BMI), which is a measure of body weight relative to height, is higher than 38

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Joseph Findley MD

Registry

ClinicalTrials.gov

Start date

24 August 2024

Est. completion

1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time in minutes from first analgesic request as measured by medical chart review; Total number of doses of rescue analgesics given as measured by medical chart review

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov